Swixx Biopharma AG is a pharmaceutical company that provides commercialization, regulatory, market access and pharmacovigilance services to international healthcare companies to introduce their products in selected markets. It operates across Central and Eastern Europe and other regions (including MENAT, Latin America and CIS) and does not conduct its own R&D or manufacturing.
AI-generated
Offering
Products & services
Industry:Funds & Investment Companies
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Commercialization platform for multinational biopharma companies in non-core markets, covering market entry, commercial execution, medical support, regulatory activities and distribution.
Market Access & Pricing
National price filings, reimbursement dossiers, pharmacoeconomic model localization, and pricing and reimbursement negotiations for partner products.
Commercial
Brand-strategy transfer, medico-marketing activities, omnichannel customer engagement capabilities, and sales force effectiveness support across markets.
Medical
Scientific exchange with societies and healthcare professionals, partner medical strategy support, training, diagnosis support, and named-patient or compassionate-use access programs where permitted.
Medical Information
Responses to healthcare professionals’ and patients’ enquiries in line with regulatory, legal and ethical standards, tailored to partner requirements.